Assembly Biosciences Inc (ASMB)
14.91
-0.13
(-0.86%)
USD |
NASDAQ |
Nov 25, 14:04
Assembly Biosciences Max Drawdown (5Y): 98.41% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.41% |
| September 30, 2024 | 98.41% |
| August 31, 2024 | 98.41% |
| July 31, 2024 | 98.41% |
| June 30, 2024 | 98.41% |
| May 31, 2024 | 98.41% |
| April 30, 2024 | 98.41% |
| March 31, 2024 | 98.41% |
| February 29, 2024 | 98.41% |
| January 31, 2024 | 98.41% |
| December 31, 2023 | 98.41% |
| November 30, 2023 | 98.41% |
| October 31, 2023 | 98.41% |
| September 30, 2023 | 98.41% |
| August 31, 2023 | 98.41% |
| July 31, 2023 | 98.41% |
| June 30, 2023 | 98.41% |
| May 31, 2023 | 98.41% |
| April 30, 2023 | 98.41% |
| March 31, 2023 | 98.41% |
| February 28, 2023 | 98.30% |
| January 31, 2023 | 98.30% |
| December 31, 2022 | 98.30% |
| November 30, 2022 | 97.97% |
| October 31, 2022 | 97.90% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.90% |
| August 31, 2022 | 97.90% |
| July 31, 2022 | 97.90% |
| June 30, 2022 | 97.90% |
| May 31, 2022 | 97.90% |
| April 30, 2022 | 97.72% |
| March 31, 2022 | 97.72% |
| February 28, 2022 | 97.72% |
| January 31, 2022 | 97.35% |
| December 31, 2021 | 96.68% |
| November 30, 2021 | 96.49% |
| October 31, 2021 | 95.20% |
| September 30, 2021 | 95.11% |
| August 31, 2021 | 94.72% |
| July 31, 2021 | 94.72% |
| June 30, 2021 | 94.08% |
| May 31, 2021 | 94.08% |
| April 30, 2021 | 95.15% |
| March 31, 2021 | 95.19% |
| February 28, 2021 | 95.52% |
| January 31, 2021 | 95.52% |
| December 31, 2020 | 95.52% |
| November 30, 2020 | 95.52% |
| October 31, 2020 | 95.52% |
| September 30, 2020 | 95.52% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.08%
Minimum
May 2021
98.41%
Maximum
Mar 2023
96.98%
Average
97.81%
Median
Max Drawdown (5Y) Benchmarks
| ADMA Biologics Inc | 84.77% |
| Sensus Healthcare Inc | 87.51% |
| Protagonist Therapeutics Inc | 85.79% |
| Precision BioSciences Inc | -- |
| Entrada Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -48.83 |
| Beta (5Y) | 0.5827 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.95% |
| Historical Sharpe Ratio (5Y) | -0.6777 |
| Historical Sortino (5Y) | -0.9803 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.15% |